CV Lattes
GoogleMyCitations
ResearcherID
ORCID
Fundação Getúlio Vargas (FGV). Escola de Administração de Empresas (EAESP) (Institutional affiliation for the last research proposal) Birthplace: Brazil
graduation at Formação de Psicologo e Bacharelado em Psicologia from Pontifícia Universidade Católica do Rio de Janeiro (2001), master's at Collective Health from Fundação Oswaldo Cruz (2005), doctorate at Collective Health from Fundação Oswaldo Cruz (2008) and doctorate at Politica Social from University of Edinburgh (2011). Has experience in Political Science, focusing on Public Politics, acting on the following subjects: políticas públicas, aids, redução de danos, pts and drogas. (Source: Lattes Curriculum)
| Articles published in Pesquisa FAPESP Magazine about the researcher: |
| El tejido de las políticas sanitarias |
| Crafting healthcare policy |
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
The novel coronavirus (COVID-19) pandemic, which has resulted in high mortality and morbidity rates, represents a challenge to health systems and services across the globe. How have governments responded to this pandemic? What is the gap in timing between the emergence of cases in a given country and that government's decision to enact control measures? Perhaps more importantly: how and w…
The Brazilian government has invested in its pharmaceutical sector as part of an innovative strategy for economic and technological development. In parallel, it increased access to high-cost medicines such as drugs to treat cancer or AIDS through the National Health System. Social science scholars have paid relatively little attention to these initiatives, focusing instead on the impact o…
This proposal aims at strengthening a four-year collaboration between Shadlen and Fonseca on studies related to regulation of pharmaceutical industries. This grant will allow us to fine-tune a typology for comparing national approaches toward the regulation of generic drugs, and to map out a research strategy for applying this typology in the Latin American. Generic drug substitution may …
The student will make a historic recovery of the changes in the financing model of the Brazilian Unified Health System since the promulgation of the Federal Constitution of 1988 until the year 2016. He will seek to establish the causal network and the causal mechanisms that explain the development of the Brazilian health financing policy, which will require a refined understanding of the …
The student will assist data collection, organization and analysis of secondary data on Brazil's experience with the health-industry complex. This will include information from different Ministries and credit lines to the pharmaceutical industry, as well as legislation and resolutions on the health-industry complex. In addition, the student will collect information on the preferences of c…
The student will assist data collection, organization and analysis of secondary data on Brazil's experience with the health-industry complex. This will include information from different Ministries and credit lines to the pharmaceutical industry, as well as legislation and resolutions on the health-industry complex. In addition, the student will collect information on the preferences of c…
(Only some records are available in English at this moment)
Ever since its beginning, in December 2016, the project "Policies for competitiveness in the pharmaceutical sector: an analysis of the Brazilian experience", led by researcher Elize Massard da Fonseca, has carried out analyzes and important results on policies involving products and services in the Industrial Health Complex in Brazil. Recently the project has strengthened ties with intern…
The student will assist data collection, organization, and analysis of secondary data on Brazil's experience with the health-industry complex. This will include information from different Ministries and credit lines to the pharmaceutical industry, as well as legislation and resolutions on the health-industry complex. In addition, the student will collect information on the preferences of …
(Only some records are available in English at this moment)
The COVID-19 pandemic is a great challenge for global public health, and it is testing health systems, evidencing, however, that state capacity is not enough to explain the countries performance in fighting disease. It is also necessary to analyze the "political capacity" to respond to epidemics. We are moving towards a consensus that the role of central governments and intergovernmental …
One of the critical problems of contemporary global health is how to provide access to life-saving direct-acting antivirals (DAAs) to treat the hepatitis C virus (HCV). DAAs are recently launched drugs that have demonstrated cure rates exceeding 90%, which has revolutionized the fight against this epidemic. Given the promising results of such therapies, the World Health Organization launc…
Government support for pharmaceutical industries lies at the heart of the tension between nations' commitment to economic liberalization while its elected officials are under pressure to respond to their constituencies. British pharmaceutical industries are one of the most innovative in the world; and Brexit, the referendum that determined the UK's withdrawal from the European Union (EU),…
(Only some records are available in English at this moment)
| 2 / 2 | Ongoing research grants |
| 1 / 1 | Completed research grants |
| 7 / 7 | Ongoing scholarships in Brazil |
| 13 / 12 | Completed scholarships in Brazil |
| 5 / 5 | Completed scholarships abroad |
| 28 / 27 | All research grants and scholarships |
| Associated processes | |
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
| Publications | 12 |
| Citations | 8 |
| Cit./Article | 0.7 |
| Data from Web of Science | |
DA FONSECA, ELIZE MASSARD; BASTOS, FRANCISCO INACIO. Implementing Intellectual Property of Pharmaceuticals in Middle-Income Countries: A Case Study of Patent Regulation in Brazil. JOURNAL OF HEALTH POLITICS POLICY AND LAW, v. 41, n. 3, p. 423-450, JUN 2016. Web of Science Citations: 0. (14/07725-3)
DA FONSECA, ELIZE MASSARD; SHADLEN, KENNETH C.. Promoting and regulating generic medicines: Brazil in comparative perspective. Revista Panamericana de Salud Pública = Pan American Journal of Public Health, v. 41, 2017. Web of Science Citations: 1. (15/18604-5, 14/07725-3)
DA FONSECA, ELIZE MASSARD; SHADLEN, KENNETH; BASTOS, FRANCISCO INACIO. Integrating Science, Technology and Health Policies in Brazil: Incremental Change and Public Health Professionals as Agents of Reform. JOURNAL OF LATIN AMERICAN STUDIES, v. 51, n. 2, p. 357-377, MAY 2019. Web of Science Citations: 0. (15/18604-5)
DA FONSECA, ELIZE MASSARD; BASTOS, FRANCISCO INACIO. Evolution of HIV/AIDS response in Brazil: Policy innovations and challenges in the fourth decade of the epidemic. INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT, v. 33, n. 1, p. E238-E250, JAN-MAR 2018. Web of Science Citations: 2. (15/18604-5)
DA FONSECA, ELIZE MASSARD. How can a policy foster local pharmaceutical production and still protect public health? Lessons from the health-industry complex in Brazil. GLOBAL PUBLIC HEALTH, v. 13, n. 4, p. 489-502, 2018. Web of Science Citations: 5. (15/18604-5, 14/07725-3)
DA FONSECA, ELIZE MASSARD; TEIXEIRA, MARIANA RAMOS; COSTA, NILSON DO ROSARIO. Building effective collaboration between health systems and the life sciences industry. DEVELOPMENT IN PRACTICE, v. 29, n. 7, JULY 2019. Web of Science Citations: 0. (18/06997-0, 15/18604-5)